Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04318327 |
| Title | BCMA-directed CAR-T Cell Therapy in Adult Patients With Relapsed and/or Refractory Multiple Myeloma |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ISR | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Uni of Chi Medi Ctr Hema and Onco | Chicago | Illinois | 60637 | United States | Details | |
| Beth Israel Deaconess Medical Cente | Boston | Massachusetts | 02215 | United States | Details | |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | United States | Details | |
| Novartis Investigative Site | Melbourne | Victoria | 3004 | Australia | Details | |
| Novartis Investigative Site | Ramat Gan | 5265601 | Israel | Details | ||
| Novartis Investigative Site | Tel Aviv | 6423906 | Israel | Details | ||
| Novartis Investigative Site | Singapore | 119074 | Singapore | Details | ||
| Novartis Investigative Site | Singapore | 169608 | Singapore | Details |